Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Jean-Baptiste Bachet"'
Autor:
Alix Riescher-Tuczkiewicz, Jules Grégory, Frederic Bert, Magaly Zappa, Anna Pellat, Valerie Lalande, Claire Gallois, Jean-Luc Mainardi, Jean-Baptiste Bachet, Jérôme Robert, Anne Sophie Bourrel, Romain Coriat, Dominique Thabut, Pascal Hammel, Vinciane Rebours, Diane Lorenzo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Bacterial peritonitis (BP) in patients with gastrointestinal (GI) cancer has been poorly described, and its prevalence is unknown. Objectives: This study aimed to evaluate in patients with both GI cancer and ascites the prevalence of BP,
Externí odkaz:
https://doaj.org/article/9469839eaa3748fe8859dc502c9b912f
Autor:
Julien Taieb, Timothy Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background PRECONNECT was an international, phase IIIb trial evaluating the safety and efficacy of trifluridine/tipiracil (FTD/TPI) for metastatic colorectal cancer (mCRC). Methods Patients with mCRC received FTD/TPI 35 mg/m2 twice-daily on
Externí odkaz:
https://doaj.org/article/c29a504b030d4e2fb5ded3f0ac9c5e4b
Autor:
Sahir Javed, Stéphane Benoist, Patrick Devos, Stéphanie Truant, Rosine Guimbaud, Astrid Lièvre, David Sefrioui, Romain Cohen, Pascal Artru, Aurélien Dupré, Jean-Baptiste Bachet, Christelle de la Fouchardière, Anne Ploquin, Anthony Turpin
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background BRAF V600E-mutant colorectal cancers (CRCs) are associated with shorter survival than BRAF wild-type tumors. Therapeutic decision-making for colorectal liver metastases (CRLM) harboring this mutation remains difficult due to the s
Externí odkaz:
https://doaj.org/article/396f97762c6d4546b3a537ee0d4435cb
Autor:
Anthony Turpin, Cindy Neuzillet, Elise Colle, Nelson Dusetti, Rémy Nicolle, Jérôme Cros, Louis de Mestier, Jean-Baptiste Bachet, Pascal Hammel
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Mortality from pancreatic ductal adenocarcinoma (PDAC) is increasing worldwide and effective new treatments are urgently needed. The current treatment of metastatic PDAC in fit patients is based on two chemotherapy combinations (FOLFIRINOX and gemcit
Externí odkaz:
https://doaj.org/article/95070b05a7e54ac5a54c741d25f47b1d
Autor:
Antoine Brouquet, Jean-Baptiste Bachet, Florence Huguet, Mehdi Karoui, Pascal Artru, Charles Sabbagh, Jérémie H. Lefèvre, Dewi Vernerey, Christophe Mariette, Eric Vicaut, Stephane Benoist, on behalf the FRENCH , GRECCAR, PRODIGE study groups
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Preoperative radiochemotherapy (RCT) is recommended in France prior to total mesorectal excision in patients with mid or low locally advanced rectal cancer (LARC) (cT3/T4 and/or N+) because it has been shown to improve local contr
Externí odkaz:
https://doaj.org/article/59be30ea6a724d6a9bcdf9f39ba3ef50
Autor:
Olivier Lucidarme, Mathilde Wagner, Paul Gillard, Stefano Kim, Jean-Baptiste Bachet, Benoit Rousseau, Thibault Mazard, Christophe Louvet, Benoist Chibaudel, Romain Cohen, Marie-Line Garcia-Larnicol, Aurelien Gobert, Julie Henriques, Thierry André
Publikováno v:
Cancer Imaging, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background To evaluate the objective response rate (ORR) at 2 months of treatment with regorafenib according to RECIST 1.1, Choi, and modified Choi (mChoi) criteria in patients with metastatic colorectal cancer (mCRC). Methods Baseline and 2
Externí odkaz:
https://doaj.org/article/973c8ae8421d499f81e57995cfc895d0
Autor:
Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Taïeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault, Valerie Taly
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background: Cellular-cell free-DNA (ccfDNA) is being explored as a diagnostic and prognostic tool for various diseases including cancer. Beyond the evaluation of the ccfDNA mutational status, its fragmentation has been investigated as a potential can
Externí odkaz:
https://doaj.org/article/e638b9a1871d45d79e5c8adad9bc53a5
Autor:
Emilie Charton, Jean‐Baptiste Bachet, Pascal Hammel, Jérôme Desramé, Benoist Chibaudel, Romain Cohen, Philippe Debourdeau, Jérome Dauba, Thierry Lecomte, Jean‐François Seitz, Christophe Tournigand, Thomas Aparicio, Véronique Guerin‐Meyer, Julien Taieb, Julien Volet, Christophe Louvet, Amélie Anota, Franck Bonnetain
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5079-5088 (2019)
Abstract Background The phase II AFUGEM GERCOR trial aimed to assess the efficacy of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine (gemcitabine group) or simplified leucovorin and fluorouracil (sLV5FU2 group) in patients w
Externí odkaz:
https://doaj.org/article/ea9e9d8aac3c4e91a964a297380cb6f7
Autor:
Fotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, Feng-Che Kuan, Teresa Macarulla, Filippo Pietrantonio, Rui-Hua Xu, Hiroya Taniguchi, Thomas Winder, Satoshi Yuki, Shan Zeng, Tanios Bekaii-Saab
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC) has improved considerably, leading to increased overall survival and more patients eligible for third- or later-line therapy. Currently, two oral therapies are re
Externí odkaz:
https://doaj.org/article/bdbcb8758a224896ae3cf4acb82af402
Autor:
Timothy Price, Chiara Cremolini, Alfredo Falcone, Eric Van Cutsem, Julien Taieb, Jean-Marc Phelip, Jean-Baptiste Bachet, Lucjan Wyrwicz, Fabienne Portales, Ahmet Ozet, Irfan Cicin, Dan Atlan, Martin Becquart, Loick Vidot, Nadjat Mounedji
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/f278b869784d4e0e9c442dc4a12a9eff